| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/19/2005 | US6881560 Introducing into a host, for expression of genes encoding enzymes required for synthesis of non-polyhydroxybutyrate and copolymer, a selected genes enzymes in combination of regulatory sequence to express the genes to encode enzymes |
| 04/19/2005 | US6881559 Enzymatic polypeptide for use as amplification tool in genetic engineering |
| 04/19/2005 | US6881558 Plasmid comprising elements which suppress expression of viral genes coding viral envelope proteins and/or microorganismal endotoxin proteins |
| 04/19/2005 | US6881557 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences |
| 04/19/2005 | US6881556 Nucleotide sequences for use as tools in controlling gene expression in genetic engineering |
| 04/19/2005 | US6881555 AKT nucleic acids, polypeptides, and uses thereof |
| 04/19/2005 | US6881552 Human protease associated proteins |
| 04/19/2005 | US6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 04/19/2005 | US6881544 Amplification of viral nucleotide sequences or use as diagnostic tools; obtain nucleotide sequences, incubate with enzyme, amplify, recover nucleotide sequence products |
| 04/19/2005 | US6881543 Sampling and storage system for genetic material from tissue |
| 04/19/2005 | US6881538 Polymeric substrate comprising relaxed oriented film or elastomeric material for preparing miniaturized microarrays to be used in sequencing, monitoring gene expression, genetic mapping and drug discovery |
| 04/19/2005 | US6881537 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1 |
| 04/19/2005 | US6881433 Novel plants having an altered ability to produce starch, including an improved ability to produce structurally-altered starch or starch of altered quality are disclosed. The invention further relates to processes for obtaining such |
| 04/19/2005 | US6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 04/19/2005 | US6881410 Treatment of E. faecium infection |
| 04/19/2005 | US6881404 Enzymatic protein for treating inflammation, thrombosis andrestenosis |
| 04/19/2005 | US6881402 Treating the cell with a Receptor Internalization and Degradation (RID) protein complex; antitumor agents; treating degenerative and immune disorders |
| 04/19/2005 | US6881395 Ligand for use as tool in the treatment of tumors in humans |
| 04/19/2005 | US6881317 Fractionation of macro-molecules using asymmetric pulsed field electrophoresis |
| 04/19/2005 | CA2312591C Poly adp-ribose polymerase gene and its uses |
| 04/19/2005 | CA2265252C Angiogenic factor and use thereof in treating cardiovascular disease |
| 04/19/2005 | CA2263713C Lyophilization of cultured human cells to preserve rna and dna |
| 04/19/2005 | CA2213223C Methods for maintaining sterility in plants |
| 04/19/2005 | CA2139507C Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 04/19/2005 | CA2059137C Enhancement of musculature in animals |
| 04/14/2005 | WO2005034003A1 Novel method for analyzing data collected by microarray experiment and the like |
| 04/14/2005 | WO2005033700A1 Method of screening insulin resistance-improving agent |
| 04/14/2005 | WO2005033699A2 Materials and methods relating to breast cancer classification |
| 04/14/2005 | WO2005033694A2 Novel antisense oligomers and use thereof |
| 04/14/2005 | WO2005033662A2 Foreign pas ligands regulate pas domain function |
| 04/14/2005 | WO2005033337A1 Oligonucleotide to be used in determining sporogenous aerobic bacterium and determination method and determination kit for sporogenous aerobic bacerium using the same |
| 04/14/2005 | WO2005033326A2 Method of extending single-stranded nucleic acid, single-stranded nucleic acid extending apparatus and dna chip |
| 04/14/2005 | WO2005033322A1 Methods and tools for the chromosomal modification of bacteria |
| 04/14/2005 | WO2005033321A2 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/14/2005 | WO2005033320A1 Packaging cells for recombinant adenovirus |
| 04/14/2005 | WO2005033319A2 Stacking crop improvement traits in transgenic plants |
| 04/14/2005 | WO2005033318A2 Methods for enhancing stress tolerance in plants and methods thereof |
| 04/14/2005 | WO2005033317A1 Chimeric carrier molecules for the production of mucosal vaccines |
| 04/14/2005 | WO2005033316A2 Secretion of proteins from yeasts |
| 04/14/2005 | WO2005033315A1 Methods and compositions for defining gene function |
| 04/14/2005 | WO2005033314A2 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | WO2005033312A1 C1q related protein |
| 04/14/2005 | WO2005033311A2 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
| 04/14/2005 | WO2005033309A2 Plant promoters and methods of use thereof |
| 04/14/2005 | WO2005033308A1 Schizophrenia-associated protein and gene coding for the same |
| 04/14/2005 | WO2005033306A1 Transformed cell, process for producing protein using the cell, protein production kit, dna fragment for expressing virus vector, use of the same, process for producing transformant for protein production, transformant for protein production obtained by the method and utilization thereof |
| 04/14/2005 | WO2005033305A1 PROCESS FOR PRODUCING INTERMEDIATE OF USEFUL ALKALOID BIOSYNTHESIS ACCORDING TO RNAi METHOD |
| 04/14/2005 | WO2005033291A2 Hormone response element binding transregulators |
| 04/14/2005 | WO2005033289A2 Transfection reagents |
| 04/14/2005 | WO2005033287A2 Methods for identifying a biosynthetic pathway gene product |
| 04/14/2005 | WO2005033285A2 GENE MODULATION BY RB2/p130 EXPRESSION |
| 04/14/2005 | WO2005033281A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 04/14/2005 | WO2005033277A2 Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase |
| 04/14/2005 | WO2005033274A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 04/14/2005 | WO2005033270A2 Vectors and transfected cells |
| 04/14/2005 | WO2005033269A2 Methods for inducing an immune response via oral administration of an adenovirus |
| 04/14/2005 | WO2005033137A1 Modified ciliary neurotrophic factor polypeptides with reduced antigenicity |
| 04/14/2005 | WO2005033136A1 Unique integrin binding site in connective tissue growth factor (ctgf) |
| 04/14/2005 | WO2005033134A2 Secreted protein therapeutics and uses thereof |
| 04/14/2005 | WO2005033132A2 Igf binding proteins |
| 04/14/2005 | WO2005033094A2 Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol |
| 04/14/2005 | WO2005032646A2 Apparatus for generating electrical pulses and methods of using the same |
| 04/14/2005 | WO2005032597A1 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 04/14/2005 | WO2005032596A1 Lentiviral apoe2 gene therapy |
| 04/14/2005 | WO2005032595A2 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 04/14/2005 | WO2005032593A1 Polyarginine-modified liposome capable of transferring into nucleus |
| 04/14/2005 | WO2005032586A1 Optimized expression of hpv 45 l1 in yeast |
| 04/14/2005 | WO2005032561A1 INVENTION RELATING TO FUNCTION OF HIV-Vpr |
| 04/14/2005 | WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/14/2005 | WO2005032487A2 Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus |
| 04/14/2005 | WO2005032486A2 A NOVEL SIRNA-BASED APPROACH TO TARGET THE HIF-α FACTOR FOR GENE THERAPY |
| 04/14/2005 | WO2005032473A2 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials |
| 04/14/2005 | WO2005032457A2 Vectors and methods for immunization against norwalk virus using transgenic plants |
| 04/14/2005 | WO2005032455A2 Combinatorially selected phosphorodithioate aptamer targeting ap-1 |
| 04/14/2005 | WO2005032343A2 Hedgehog signaling in prostate regeneration neoplasia and metastasis |
| 04/14/2005 | WO2005032245A1 Method of producing transgenic pigs expressing green fluorescent protein |
| 04/14/2005 | WO2005032244A1 Transgenic animals with serious disorders related to alzheimer's disease |
| 04/14/2005 | WO2005032241A1 Eucalyptus transformation method |
| 04/14/2005 | WO2005017170A3 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
| 04/14/2005 | WO2005003778A3 A method for identifying a synthetic molecule having affinity towards a target |
| 04/14/2005 | WO2005003322A3 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 04/14/2005 | WO2005003315A3 Compositions and methods for peptide-assisted transfection |
| 04/14/2005 | WO2005002512A3 Immunotherapeutic vaccine strategy |
| 04/14/2005 | WO2004113546A3 CASTANEA SATIVA MILL. GENES CODIFYING FOR ALLENE OXIDE CYCLASE, CYSTATIN, β-1,3-GLUCANASE AND THAUMATIN-LIKE PROTEIN AND THEIR USE |
| 04/14/2005 | WO2004111190A3 IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES |
| 04/14/2005 | WO2004108890A3 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms |
| 04/14/2005 | WO2004096257A8 Genetic modification of targeted regions of the cardiac conduction system |
| 04/14/2005 | WO2004092395A3 Modulators of telomere stability |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2004083378A3 Mammalian cell lines specifically deficient in o-linked glycosylation |
| 04/14/2005 | WO2004070019A3 Membrane active polymers |
| 04/14/2005 | WO2004067728A3 Methods and systems for the identification of rna regulatory sequences and compounds that modulate their function |
| 04/14/2005 | WO2004063350A3 Highly controllable electroporation and applications thereof |
| 04/14/2005 | WO2004063333B1 Seed-oil suppression to enhance yield of commercially important macromolecules |
| 04/14/2005 | WO2004052311A3 Modulation of acteyl-coa acetyltransferase 2 expression |
| 04/14/2005 | WO2004048533A3 Modulation of forkhead box c2 expression |
| 04/14/2005 | WO2004047612A3 Methods of therapy and diagnosis |
| 04/14/2005 | WO2004046168A3 Recombinant hiv-1 subclass d envelope glycoproteins |
| 04/14/2005 | WO2004044140A3 2’-substituted oligomeric compounds and compositions for use in gene modulations |
| 04/14/2005 | WO2004037981A3 Triplex-forming oligonucleotides containing modified purines and their applications |